Work

Cost–effectiveness analysis of nivolumab in the second-line treatment for advanced esophageal squamous cell carcinoma

Year: 2020

Type: article

Source: Future Oncology

DOI: 10.2217/fon-2019-0821

Authors: Peng-Fei Zhang, Dan Xie, Qiu Li

Institutions: Sichuan University, West China Medical Center of Sichuan University, West China Hospital of Sichuan University, West China Second University Hospital of Sichuan University

Language: English

Topic: Health Systems, Economic Evaluations, Quality of Life

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Natural Science Foundation of China

OpenAlex ID: W3025967965

FWCI: 7.853

Cites: 32

Cited by: 55

Related to: 10